Duchenne muscular dystrophy: open trials in China

• NCT07188012

  Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

  Trial Treatment · Early phase 1 · Shanghai Siponuoyin Biotechnology Co Ltd

  Shanghai Children's Medical Center, Shanghai

  Registry updated 2026-11-05

• NCT07511920

  A Multicenter Cohort Study of Duchenne and Becker Muscular Dystrophy in Western Chinese Children

  Research · West China Second University Hospital

  West China Second University Hospital, Sichuan University, Chengdu

  Registry updated 2026-04-06

• NCT07058662

  A Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of BBM-D101 in the Treatment of Duchenne Muscular Dystrophy.

  Trial Treatment · Phase 1/2 · Belief BioMed (Beijing) Co., Ltd

  Peking Union Medical College Hospital, Beijing

  Registry updated 2025-12-04

• NCT06900049

  Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

  Trial Treatment · Early phase 1 · Shanghai Jiao Tong University School of Medicine

  Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai

  Registry updated 2025-04-02

• NCT06641895

  Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy

  Trial Treatment · Early phase 1 · Shanghai Jiao Tong University School of Medicine

  Shanghai Children's Medical Center Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai

  Registry updated 2025-03-25

• NCT04012671

  A Registered Cohort Study on Duchenne Muscular Dystrophy

  Research · Ning Wang, MD., PhD.

  First Affiliated Hospital of Fujian Medical University, Fuzhou

  Registry updated 2021-03-22

All Duchenne muscular dystrophy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error